The groundbreaking approach of the medication represents a major breakthrough in the handling of diabetes mellitus type 2. Different to existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 https://tirzepatidepeptide257472.gynoblog.com/40773740/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment